aTyr Pharma, Inc.
aTyr Pharma, Inc.
Healthcare

NASDAQ:ATYR · NASDAQ Global Market

Market Cap $58.10M Beta 0.54 P/E (TTM) -0.7
$0.59 +14.23%

+$0.07 today

52W Low $0.40High $7.29

Vol 1.48M · Avg 2.29M

EPS (TTM) -$0.71Biotechnology

Dividends

Measure the reliability of shareholder income

Look beyond the current yield by checking payout history, cash support, buybacks, and other ways management returns capital to owners.

Dividend analysis for aTyr Pharma, Inc. should look at more than the latest yield. Review ATYR payout history, free cash flow support, buybacks, balance sheet flexibility, and peer income metrics together so the shareholder return profile is judged by durability, not by a single headline percentage that may change with price movement.

Dividends

Dividend history, growth & yield

Dividends

Yield

0.00%

Annual Div/Share

$0.00

Payout Ratio

0.0%

Frequency

Shareholder Yield

0.00%

Next Ex-Date

Not announced

Next Payment

Analysis

The current indicated dividend yield is 0.00%. The payout ratio is 0.0%, so compare payout growth against earnings coverage.

Shareholder Returns

Dividend, buyback & debt paydown yields

Management

Dividend Yield (TTM)

0.00%

Buyback Yield (TTM)

0.00%

Debt Paydown (TTM)

0.95%

Total Yield (TTM)

0.95%

Showing limited history. Sign in for more

Analysis

Total TTM shareholder yield is 0.95% including 0.95% from debt paydown. The largest current contributor is debt paydown at 0.95%, which helps show whether capital returns are coming from direct cash payouts, share count reduction, or balance sheet cleanup.

Competitor Dividends

Peer payout, dividend, and buyback comparison

No competitor dividend data available.

Does ATYR stock pay dividends?

aTyr Pharma, Inc. (ATYR) currently pays a dividend. The indicated dividend per share is 0.00 USD and the dividend yield is 0.00%.

Is ATYR's dividend covered?

The payout ratio is 0.0%, so compare that against earnings and free cash flow before relying on the dividend.

Explore More

Continue the stock analysis

Jump to another research area for this company.